Related Experiment Video
Updated: Feb 7, 2026

Ultrasonic Assessment of Myocardial Microstructure
Published on: January 14, 2014
Modulation of antibiotic effect by Fe2(MoO4)3 microstrutures
T S Freitas1, F S Oliveira1, R P Cruz1
1Laboratório de Microbiologia e Biologia Molecular, Universidade Regional do Cariri, CEP 63105-000 Crato, CE, Brazil.
Iron molybdate (Fe2(MoO4)3) microstructures show no direct antibacterial effect. However, they antagonize common antibiotics, increasing their minimum inhibitory concentration (MIC) due to pro-oxidative properties.
Area of Science:
- Materials Science
- Nanotechnology
- Microbiology
Background:
- Metallic oxides are explored for antimicrobial applications.
- Understanding the interaction between novel materials and antibiotics is crucial for drug development.
- Iron molybdate (Fe2(MoO4)3) microstructures were synthesized hydrothermally.
Purpose of the Study:
- To investigate the antibacterial activity of Fe2(MoO4)3 microstructures.
- To evaluate the modulatory effect of Fe2(MoO4)3 on existing antibiotic activity.
- To characterize the synthesized Fe2(MoO4)3 material.
Main Methods:
- Hydrothermal synthesis of Fe2(MoO4)3 without surfactants.
- Material characterization using X-ray diffraction (XRD), Raman spectroscopy, and scanning electron microscopy (SEM).
- Antibacterial assays against Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus using microdilution method, evaluating both direct and antibiotic-modulatory effects.
Main Results:
- Fe2(MoO4)3 crystallized in a monoclinic structure with a ball-of-yarn morphology.
- Fe2(MoO4)3 exhibited no significant direct antibacterial activity (MIC ≥ 1024 μg/mL).
- Fe2(MoO4)3 showed an antagonistic effect when combined with gentamicin, norfloxacin, and imipenem, increasing their MIC values.
Conclusions:
- The antagonistic effect is attributed to the pro-oxidative properties of Fe2(MoO4)3, leading to increased free radical production.
- Potential coordination of iron with antibiotics may reduce antibiotic efficacy.
- Fe2(MoO4)3 is unsuitable for direct clinical antimicrobial use or as an adjunct therapy with antibiotics.
Related Concept Videos
Antibiotic Selection
Development of Antibiotic Resistance
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3
Piaget's Stage 3 of Cognitive Development
Conservation and Constancy of Quantity
A significant cognitive milestone in the...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

